<DOC>
	<DOCNO>NCT01640171</DOCNO>
	<brief_summary>Since 2004 , intravitreal injection Avastin , Lucentis , Macugen wet age-related macular degeneration , retinal vein occlusion , diabetic macular edema administer United States increase rate . A 2010 study show Canada incidence injection grow 8 fold 2005 2007 25.9 injection per 100,000 citizen . ( Campbell 2010 ) In 2009 , United States , 1 million intravitreal injection administer Medicare beneficiary . ( Wykoff 2011 ) In year 2011 , four doctor retina group administer total 6,494 intravitreal injection ; 2010 , administer 5021 intravitreal injection . Even though intravitreal injection commonly administer , optimal method anesthetize eye prior injection yet determine . Some physician use anesthetic drop , soak cotton pledget , use anesthetic gel use subconjunctival inject anesthetic . In 2009 , last time Procedures Trends Survey ( PAT ) ( Mittra 2009 ) conduct American Society Retina Specialists ( large retina society world ) ask anesthetic method administer intravitreal injection , follow response give 433 respondent : - Topical anesthetic drop : 21.48 % - Topical viscous anesthetic : 23.33 % - Topical anesthetic &amp; soak cotton-tip pledget : 29.79 % - Subconjunctival injection anesthetic : 24.02 % - Other : 1.39 % An editorial 2011 journal Retina , discuss lack good study assess optimal anesthetic prior intravitreal injection . ( Prenner 2011 ) .</brief_summary>
	<brief_title>Anesthesia Preference Intravitreal Injection : Topical Subconjunctival</brief_title>
	<detailed_description>Topical lidocaine gel without subconjunctival lidocaine injection intravitreal injection : within-patient study Research Protocol Steven M. Cohen , MD 1 &amp; 2 . General information include rationale study . Explain area Current scientific concern research need ; Background information include description exist research information already know topic ; Since 2004 , intravitreal injection Avastin , Lucentis , Macugen wet age-related macular degeneration , retinal vein occlusion , diabetic macular edema administer United States increase rate . In Canada , incidence intravitreal injection grow 8 fold 2005 2007 25.9 injection per 100,000 citizen . ( Campbell 2010 ) In 2009 , United States , 1 million intravitreal injection administer Medicare beneficiary . ( Wykoff 2011 ) In year 2011 , four doctor retina group administer total 6,494 intravitreal injection ; 2010 , administer 5021 intravitreal injection . Even though intravitreal injection commonly administer , optimal method anesthetize eye prior injection yet determine . Some physician use anesthetic drop , use soak cotton pledget , use anesthetic gel use subconjunctival inject anesthetic . In 2009 , last time Procedures Trends Survey ( PAT ) ( Mittra 2009 ) conduct American Society Retina Specialists ( large retina society world ) ask anesthetic method administer intravitreal injection , follow response give 433 respondent : - Topical anesthetic drop : 21.48 % - Topical viscous anesthetic : 23.33 % - Topical anesthetic &amp; soak cotton-tip pledget : 29.79 % - Subconjunctival injection anesthetic : 24.02 % - Other : 1.39 % In 2005 , 12 patient study give subconjunctival lidocaine injection prior intravitreal injection subsequently ( another visit ) give topical gel anesthesia prior intravitreal injection . The patient rat pain scale 0 10 . These researcher find pain score two group patient receive subconjunctival anesthetic chemosis subconjunctival hemorrhage . This study small power determine difference group . ( Friedman 2005 ) In 2006 , study compare topical gel subconjunctival lidocaine injection use analog pain scale one hundred patient find difference two group ( N=100 ) . The intravitreal injection give within 30 second first anesthetic application : application anesthetic gel injection subconjunctival lidocaine . ( Freeman 2006 ) In patient , lidocaine take long 30 second work . A study 2 % lidocaine dental procedure show onset anesthetic tooth 3.3 +/- 1.5 minute ( average +/- SD ) . ( Oka 1997 ) In 2012 , study compare various topical anesthetic agent publish show significant difference topical proparicaine drop , 4 % lidocaine solution , 3.5 % lidocaine gel group 120 patient use analog pain scale 0 10 . This study perform intravitreal injection 20 70 second first anesthetic application . ( Davis 2012 ) In 2012 , study perform 60 patient compare tetracaine , proparacaine , TetraVisc gel find tetracaine least painful . They also find significantly low pain score patient improve vision previous injection , female sex , age &gt; 65 . This suggest factor anesthetic type use might affect result pain study . ( Rifkin , 2012 ) An editorial 2011 journal Retina , discuss lack good study assess optimal anesthetic prior intravitreal injection . ( Prenner 2011 ) . 3 . The research question , objective purpose ; To determine topical gel subconjunctival lidocaine superior topical gel relieve pain intravitreous injection anti-vascular endothelial growth factor medication . 4 . The study design include information need answer research question ; Study Design : This within patient , factorial , single blind , randomize trial compare topical anesthetic gel topical anesthetic gel plus subconjunctival lidocaine relieve pain intravitreous injection . Patients receive bilateral simultaneous injection wet macular degeneration retinal vein occlusion diabetic macular edema ask participate study . Those consent sign approve informed consent treat follow : A coin flip determine treatment right go get . The right eye always treat left eye , eye treat nearly simultaneously possible . Both eye prepare simultaneously leave eye receive intravitreal injection within 30 second right eye inject . In preparation injection , one drop Proparicaine Hydrochloride 0.5 % one drop brimonidine 0.2 % , instill eye follow ¼ inch TetraVisc Forte Gel . The patient instruct close eye 5-minutes . Then another application ¼ inch TetraVisc Forte Gel place inferior conjunctival fornix . Another 5-minute waiting period observe . Finally , eye randomize subconjunctival lidocaine 0.1 cc 2 % lidocaine hydrochloride , 20 mg/ml , inject subconjunctivally intend site intravitreal injection . In eye randomize subconjunctival lidocaine , pretend injection give push syringe without needle eye . Another 5-minute waiting period observe . Another drop Proparicaine Hydrochloride Solution 0.5 % place eye another ¼ inch TetraVisc Gel , sterile eyelid speculum use separate lid , eye prepped drop 5 % Betadine Solution . After Betadine prep , eye ( right left ) inject par plana , 3 mm posterior corneal scleral limbus , anti-vascular endothelial growth factor drug . Following intravitreal injection , sterile lid speculum remove . The eye irrigate sterile eye rinse eye irrigation solution drop Acuvail place eye . The patient ask keep eye mostly close one hour follow injection , use artificial tear hourly every four hour , rub eye procedure anesthetic . The patient also warn report adverse event immediately , especially escalate pain , within day two procedure . Pain rat two way procedure , compare two eye also 0 10 standardized pain scale . - Prior treatment - After subconjunctival anesthetic - After intravitreal injection - That even phone - The following day phone At 5 time , patient ask right eye compare leave eye : - Much pain right eye ; little pain right eye ; difference ; little pain leave eye ; much pain leave eye . - Rate pain eye 0 10 The final endpoint follow day patient decide eye prefer overall anesthetic therapy . They ask choose method next visit use eye . If patient preference one study visit , second study visit perform reverse treatment eye get anesthesia . Then choose method like best state two treatment . 5 . Sample size justify A sample size 44 patient would provide 80 percent probability detect important difference pain magnitude one exist assume ratio expect treatment effect standard deviation 0.6 ( two-tailed , alpha = 0.05 ) ( Friedman 2006 ) 9 . The risks subject ; These treatment anesthetic validate several large clinical study . There high risk subconjunctival hemorrhage chemosis eye subconjunctival anesthetic . Neither cause lasting harm eye , cause discomfort day two . With either anesthetic , risk : conjunctival hemorrhage , eye pain , vitreous floater , foreign body sensation , ocular discomfort . 10.Any experimental procedure include use procedure already perform subject diagnostic treatment purpose ; 11.The potential benefit subject ; This study allow patient determine optimal anesthetic protocol . From experience , patient prefer one mode anesthesia prefer another mode anesthesia . Usually physician chooses anesthetic type . This study allow patient determine type anesthetic prefer . 12.Human subject consideration include description inform consent process ; potentially vulnerable subject enrol ( e.g. , child , prisoner , cognitively impaired , institutionalize critically/terminally ill ) , include discussion additional safeguard place protect subject ; include discussion privacy confidentiality subject maintain Informed consent give verbal write day visit . Patients eligible also contact phone prior visit tell study phone . Finally , patient give option enter leave study whenever want . If want enroll initial visit study discuss , offer entry follow visit . No child , prisoner , cognitively impair terminally ill patient enrol . Finally , research note code use patient 's record number retina practice . Charts office always maintain HIPPA compliant manner . 13.Data safety monitoring plan include whether data safety monitor board associate study , often data review safety , early stopping criterion , etc . There data safety monitor board .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Proxymetacaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<mesh_term>Propoxycaine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Patient receive bilateral intravitreal injection Ability give inform consent Preexisting eye pain Uveitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>anesthesia</keyword>
	<keyword>pain</keyword>
	<keyword>intravitreal</keyword>
	<keyword>anti-vegf</keyword>
</DOC>